{"id":309692,"date":"2018-12-27T03:21:01","date_gmt":"2018-12-27T03:21:01","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=309692"},"modified":"2018-12-27T03:21:01","modified_gmt":"2018-12-27T03:21:01","slug":"medical-marijuana-market-key-players-are-focusing-on-new-approach-for-treatment-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/medical-marijuana-market-key-players-are-focusing-on-new-approach-for-treatment-2023_309692.html","title":{"rendered":"Medical Marijuana Market Key Players are Focusing on New Approach for Treatment 2023"},"content":{"rendered":"
27th December 2018: MarketResearchFuture announced addition of new report, titled \u201cMedical Marijuana Market Research Report \u2013 Forecast to 2023\u201d.\t<\/div>\n

Market Highlights<\/strong><\/p>\n

Marijuana consists of chemical components cannabinoids,  which can be used as medicine to treat the symptoms caused by illness. Medical marijuana<\/a> <\/strong>plant or extract of the plant is used for the treatment. The increasing number of chronic diseases, rising acceptance of medical marijuana in healthcare and increasing research and development activities are the major factors driving the growth of the global medical marijuana market. Additionally, increasing U.S. Food and Drug Administration (FDA) approvals for drugs containing cannabinoids are contributing to the growth of the market. For instance, in June 2018, U.S. Food and Drug Administration (FDA) has approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of epilepsy.<\/p>\n

The stringent regulatory environment for product approval, increasing use of marijuana for recreational use and side effects caused by long-term use of marijuana are likely to hinder market growth during the forecast period.<\/p>\n

GET SAMPLE REPORT @ <\/em><\/strong>https:\/\/www.marketresearchfuture.com\/sample_request\/6470<\/a> <\/em><\/strong><\/p>\n

Regional Analysis<\/strong><\/p>\n

The market in the Americas is expected to dominate the global medical marijuana market during the forecast period owing to the increasing prevalence of chronic diseases, increasing number of cannabinoid drug approvals by regulatory authorities, and increasing expenditure on research and development of medical marijuana. The European market is expected to be the second-largest due to the favorable policies implemented by government and regulatory authorities and increasing applications of marijuana in healthcare. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing number of mental disorders and increasing expenditure on healthcare research and development. The market in the Middle East & Africa is likely to account for the smallest share of the global medical marijuana market. The market growth in this region can be attributed to the rising acceptance of medical marijuana in the treatment of illness and favorable government policies.<\/p>\n

Segmentation<\/strong><\/p>\n

The global medical marijuana market has been segmented on the basis of application, route of administration and distribution channel.<\/p>\n

On the basis of application, the market has been classified as Alzheimer’s disease, cancer, mental health conditions, multiple sclerosis, muscle spasms, glaucoma, and human immunodeficiency virus, acquired immunodeficiency syndrome (HIV\/AIDS). Mental health conditions are differentiated into schizophrenia and posttraumatic stress disorder (PTSD).<\/p>\n

 The route of administration segment has been further divided into oral, topical, inhalation and sublingual. The topical segment has been classified into ointments, lotions, creams, gels, and poultice.<\/p>\n

The market, by distribution channel, has been segmented into dispensaries and online platforms.<\/p>\n

Key Players<\/strong><\/p>\n

Some of the key players in the global medical marijuana market are Canopy Growth, Aurora Cannabis, Inc., Cannabis Sativa, Inc, GW Pharmaceuticals plc, United Cannabis, MGC Pharma, Aphria, Inc., Tilray, Emerald Health Therapeutics [Canada] Inc., GBSciences, Inc., CanniMed Ltd., Medical Marijuana, Inc, Cara Therapeutics, and Greengro Technologies.<\/p>\n

 <\/p>\n

Table of Content: Key Points<\/span><\/strong><\/p>\n

Chapter 1. Report Prologue<\/p>\n

Chapter 2. Market Introduction<\/p>\n

Chapter 3. Research Methodology<\/p>\n

Chapter 4. Market Dynamics<\/p>\n

Chapter 5. Market Factor Analysis<\/p>\n

Chapter 6. Global Medical Marijuana Market, By Application<\/p>\n

…Continued                              <\/strong><\/p>\n

Access full report <\/em><\/strong>now:<\/em><\/strong>https:\/\/www.marketresearchfuture.com\/reports\/medical-marijuana-market-6470<\/em><\/strong><\/a><\/p>\n

Contact Us:<\/strong><\/p>\n

Market Research Future<\/strong><\/p>\n

Office No. 528, Amanora Chambers<\/p>\n

Magarpatta Road, Hadapsar,<\/p>\n

Pune – 411028<\/p>\n

Maharashtra, India<\/p>\n

Phone: +1 646 845 9312<\/p>\n

Email: sales@marketresearchfuture.com<\/a><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Market Research Future
Contact Person:<\/strong> Abhishek Sawant
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9312
Address:<\/strong>Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> https:\/\/www.marketresearchfuture.com\/reports\/primer-market-2109<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

27th December 2018: MarketResearchFuture announced addition of new report, titled \u201cMedical Marijuana Market Research Report \u2013 Forecast to 2023\u201d. Market Highlights Marijuana consists of chemical components cannabinoids,  which can be used as medicine to treat the symptoms caused by illness. … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-309692","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/309692","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=309692"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/309692\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=309692"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=309692"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=309692"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}